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Abstract: The national scale-up of antiretroviral therapy (ART) in
Malawi is based on the public health approach, with principles and
practices borrowed from the successful DOTS (directly observed
treatment, short course) tuberculosis control framework. The key
principles include political commitment, free care, and standardized
systems for case ﬁnding, treatment, recording and reporting, and drug
procurement. Scale-up of ART started in June 2004, and by
December 2008, 223,437 patients were registered for treatment
within a health system that is severely underresourced. The Malawi
model for delivering lifelong ART can be adapted and used for
managing patients with chronic noncommunicable diseases, the
burden of which is already high and continues to grow in low-income
and middle-income countries. This article discusses how the
principles behind the successful Malawi model of ART delivery
can be applied to the management of other chronic diseases in
resource-limited settings and how this paradigm can be used for
health systems strengthening.
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A
very poor landlocked country in southern Africa, Malawi,
has a per capita gross domestic product of less than
US $200 per year, a population of 13 million
1, and a dire HIV
epidemic. In 2004, when antiretroviral therapy (ART) was
being introduced at national scale, approximately 930,000
people were thought to be HIV infected, with another 100,000
new HIV infections occurring annually, and 170,000 people
were estimated to be in immediate need of ART.
2
National scale-up of ART commenced in June 2004,
with ﬁnancial support from the Global Fund to Fight AIDS,
Tuberculosis and Malaria. At that time, 9 health facilities in
the public sector delivered ART to about 3000 patients. ART
delivery was unstructured, very few health care workers had
been formally trained for the activity, and national systems of
monitoring or reporting did not exist. In short, what might be
called ‘‘ART anarchy’’ prevailed.
With the assistance of a well thought out national plan,
explicit national guidelines for the management and monitor-
ing of ART, and a standardized process for training health care
workers and preparing facilities for ART, this life-saving
treatment was scaled up rapidly and efﬁciently in both public
and private sectors. By December 31, 2008 (4½ years after the
start of scale-up), 170 health facilities in the public health
sector had registered 215,449 adults and children on ART, and
51 health facilities in the private sector registered 7988 adults
and children on ART.
3 Both public and private health sectors
use the same standardized systems of delivering and
monitoring treatment. By December 31, 2008, of the
223,437 patients ever registered in both public and private
sectors, 147 479 (66%) were known to be alive and on ART,
23,699 (11%) were dead, 24,409 (11%) were lost to follow-up,
27,069 (12%) had transferred out to another treatment facility,
and 781 patients were known to have stopped treatment. The
number of new patients registered increased year by year, from
10,183 in 2004 to 76,581 in 2008.
3 Although technical and
operational challenges remain in abundance, this growth has
been, andcontinuesto be,an immense achievement forMalawi
and an oft-cited example internationally. ART has already
begun to reduce adult mortality at the population level.
4
This article discusses how the principles behind the
successful Malawi model of scaling up ART can be applied
to the management of other chronic diseases in resource-
limited settings and how this paradigm can be used for health
systems strengthening.
PRINCIPLES OF ART SCALE-UP IN MALAWI
AND REASONS FOR SUCCESS
Right from the start it was recognized that ART
delivery in Malawi using a ‘‘medicalized’’ model would not
work and that the key to rapid and massive scale-up was to
keep the principles and practices of ART delivery as simple
as possible. In this regard, many of the principles of DOTS
(directly observed treatment, short course)—the system used
to successfully deliver tuberculosis (TB) treatment to people
in some of the world’s poorest countries
5—were borrowed
and adapted to ART delivery and could be similarly adapted
for other chronic diseases (Box 1). A standardized system
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for ART eligibility, initiating treatment, and registering and
reporting cases and outcomes was followed wherever ART
was being delivered from central hospital to health center and
from public health facility to private clinic. An important
policy decision was made that ART in the public sector was
to be free to all patients and subsidized for patients in the
private sector.
Of the number of factors responsible for the success of
Malawi’s ART scale-up, the most important were:
 The clear lead taken by the Ministry of Health in assuming
responsibility for national scale-up and a desire by all
implementing partners to work with the Ministry of Health
and use nationally standardized systems.
 A focus on scaling up using a single ﬁrst-line ﬁxed-dose
combination regimen, a focus that was made possible by the
fact that Malawi’s sole ART funding source was the Global
Fund.
 The existence of clear national ART guidelines, with an
emphasis also placed on the system of registration,
monitoring, and recording of results.
6,7
 An intensive training schedule focused particularly on
clinical ofﬁcers and nurses learning ART guidelines and
undertaking practical attachments at experienced ART sites.
 A structured system of accrediting ART sites before they
were permitted to deliver treatment to patients.
 Quarterly supervision and monitoring and reporting for all
ART delivery sites by the HIV Unit of the Ministry of
Health and its partners.
 An absence of ARV drug stockouts.
Because of this simpliﬁed and highly standardized
delivery model, an average of approximately 1 clinician and
1 nurse were able to manage 1000 patients on ART by the end
of 2008.
3
ADAPTING THE ANTIRETROVIRAL DELIVERY
MODEL TO MANAGEMENT OF OTHER
CHRONIC DISEASES
The prevalence and incidence of noncommunicable
diseases (NCDs) such as hypertension, diabetes mellitus,
cardiovascular disease, obstructive airways disease, and
asthma grow inexorably each year and increasingly affect
patients and communities in resource-poor settings.
8 For
example, diabetes mellitus was estimated to affect 246 million
people globally in 2007, with 6 million new cases and 3.5
million deaths; 70% of this burden was in developing
countries.
9 Similar numbers pertain to asthma: 300 million
patients are estimated to be living with the disease, with
250,000 deaths annually—the majority in developing coun-
tries.
10 Even in rural communities in southern Africa, racked
by chronic infectious diseases such as HIV/AIDS and TB, the
burden and mortality of chronic NCDs such as cardiovascular
disease, diabetes, and malignancy increases year by year.
11
Although patients with these NCDs usually need chronic
care and treatment over their lifetimes, it is simply not
provided in most resource-poor countries outside a few centers
of excellence, and there are no systems to monitor patient
access or outcomes.
BOX 1. Principles of TB Control
Principles of TB Control Delivery of ART
Application to Care of Chronic
Diseases, (eg, DM)*
Standardized diagnosis and case ﬁnding based on:
 Smear microscopy  Positive HIV test result  Blood glucose levels
 Different categories of TB
(smear-positive and smear-negative pulmonary
TB and extra pulmonary TB)
 Different WHO clinical stages (stage 3 or 4)
or a low CD4-lymphocyte count
 Different categories of DM
(type 1 or type 2)
Standardized treatment based on:
 Treatment regimen for new cases of TB  First-line ART regimen for new cases  Oral hypoglycemic drugs
 Re-treatment regimen for patients who fail,
relapse, or return after default
 Second-line ART regimen for failure  Parenteral insulin
 Dietary regimens
Standardized recording and reporting based on:
 TB patient treatment cards  ART patient treatment cards  DM patient treatment cards
 TB patient registers  ART patient registers  DM patient registers
 TB patient identity cards  ART patient identity cards  DM patient identity cards
 TB cohort analysis forms  ART cohort analysis forms  DM cohort analysis forms
Standardized system of procurement based on:
 Forecasting of new TB patients starting treatment  Forecasting of new patients starting ART  Forecasting of new patients starting treatment
 Taking into account old drug stocks  Forecasting cumulative number of
patients retained on ART
 Forecasting cumulative number of patients
retained on treatment
 Taking into account old drug stocks  Taking into account old drug stocks
Management by paramedical ofﬁcers Management by paramedical ofﬁcers Management by paramedical ofﬁcers†
Free drugs for patients in public sector Free drugs for patients in public sector Free drugs for patients in the public sector
*This example could similarly apply to other chronic diseases, such as hypertension, epilepsy, and mental illness.
†Where there are shortages of highly qualiﬁed human resources.
DM, diabetes mellitus.
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management and monitoring of lifelong ART can also be used
for patients with NCDs.
12 Simple diagnostic and treatment
protocols would be helpful for patients in chronic structured
care to ensure that standard quality treatment is maintained at
all levels of the health care system. Primary outcomes—alive,
dead, stopped therapy, lost to follow-up, and transferred out to
another treatment facility—apply to all NCDs. Quarterly
collation of data would allow regular updating of the
denominator (how many patients have started on therapy in
a facility) and the key numerator (how many patients are
retained on therapy in that facility at the end of every quarter).
The number of patients alive and on treatment can be further
subdivided into those on particular types of medication and
those with complications of the disease. The number alive and
on treatment is a vital piece of strategic information, which
provides at any set moment in time the prevalent number of
cases and thus the current burden of disease. If measured
regularly and accurately, this information would be vital for
rational drug forecasting and planning of logistics and stafﬁng.
USING CHRONIC DISEASE MANAGEMENT
PARADIGMS FOR STRENGTHENING
HEALTH SYSTEMS
Implementation of any system that seeks to provide and
monitor special quality care for patients with chronic
infectious and noninfectious diseases on a large scale must
be sensitive to the needs of the general health sector, as
otherwise there is a risk of setting up multiple parallel, or
‘‘vertical,’’ programs. This being said, many urban hospitals in
developing countries already run special clinics for patients
with diabetes mellitus, hypertension, or asthma. Consideration
could be given to merging these into single clinics for chronic
diseases as in hospitals and health centers in Cambodia,
13
where ART, diabetes, and hypertension have been successfully
managed together, and in rural centers in Ethiopia,
14 where
diabetes and epilepsy are managed together. Moreover, efforts
to reduce mother-to-child transmission of HIV should be seen
not as stand-alone interventions but rather as an integral
component of maternal and child health.
For all clinics serving special populations, regular
structured supervision is needed to ensure that monitoring
systems are of good quality, but these supervisory activities
can be developed and expanded to beneﬁt the wider health
sector and chronic diseases. There is a growing conviction that
vertical programs can be adapted to drive improvements
throughout the health system, particularly in hitherto weak
areas such as laboratory infrastructure and service delivery,
monitoring, supervision, quality assurance, and rational drug
forecasting and procurement.
15 Any attempt to better the
management and monitoring of special diseases must include
a vision of how the work will improve the health sector and
health care delivery as a whole.
CONCLUSIONS
The provision and monitoring of ART to thousands of
patients living in resource-poor countries like Malawi, based
on the DOTS framework for TB control developed during the
mid-1990s,
5 can serve as a model for managing and
monitoring the growing burden of NCDs. Malawi’s ART
scale-up was based on a strategy, guidelines, and a well
thought out plan, but the implementation was all about
learning while doing. The same principles can be applied to
the management of NCDs, with a vision and a strategy about
how to move forward and operational research used to work
out and reﬁne the all-important details.
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